Cargando…
Nanomaterials-Based Combinatorial Therapy as a Strategy to Combat Antibiotic Resistance
Since the discovery of antibiotics, humanity has been able to cope with the battle against bacterial infections. However, the inappropriate use of antibiotics, the lack of innovation in therapeutic agents, and other factors have allowed the emergence of new bacterial strains resistant to multiple an...
Autores principales: | León-Buitimea, Angel, Garza-Cárdenas, Cesar R., Román-García, María Fernanda, Ramírez-Díaz, César Agustín, Ulloa-Ramírez, Martha, Morones-Ramírez, José Rubén |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220075/ https://www.ncbi.nlm.nih.gov/pubmed/35740200 http://dx.doi.org/10.3390/antibiotics11060794 |
Ejemplares similares
-
The Demand for New Antibiotics: Antimicrobial Peptides, Nanoparticles, and Combinatorial Therapies as Future Strategies in Antibacterial Agent Design
por: León-Buitimea, Angel, et al.
Publicado: (2020) -
Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis
por: León-Buitimea, Angel, et al.
Publicado: (2021) -
Synthetic Biology Tools for Engineering Microbial Cells to Fight Superbugs
por: León-Buitimea, Angel, et al.
Publicado: (2022) -
Antibacterial Activity of combinatorial treatments composed of transition-metal/antibiotics against Mycobacterium tuberculosis
por: Montelongo-Peralta, L. Z., et al.
Publicado: (2019) -
Editorial: Facing the Upcoming of Multidrug-Resistant and Extensively Drug-Resistant Bacteria: Novel Antimicrobial Therapies (NATs)
por: León-Buitimea, Angel, et al.
Publicado: (2021)